Biotechware
Biotechware, operating as Aizoi, is an Italian digital health company that combines proprietary cardiometabolic medical devices, a CE-marked cloud platform, and a 24/7 telereferring service to deliver screening, diagnosis, and remote monitoring for hospitals, pharmacies, and clinicians across Italy.
- Company typePrivate
- Founded2011
- HeadquartersTorino, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biotechware does
Biotechware, which operates under the trade name Aizoi, is an Italian digital health company that has built an integrated telemedicine platform for cardiometabolic screening, diagnosis, and remote patient monitoring, with a particular emphasis on serving retail pharmacies in addition to hospitals, clinics, and individual healthcare professionals. Founded in 2011 and headquartered in Torino, the company combines proprietary medical hardware, a CE-marked (CE 0426) cloud platform, and a 24/7 cardiology reporting service into a single vertically integrated offering aimed at decentralizing cardiovascular diagnostics outside of traditional hospital settings.
The product portfolio spans five core medical devices and a cloud backbone. The TrAIcorder uses proprietary remote photoplethysmography (rPPG) technology with AI-driven analysis to perform contactless cardiometabolic screening of 25+ vital and metabolic parameters in 60 seconds without a blood draw. The CardioPad Lite is a next-generation resting electrocardiograph with health card integration; the Eclipse PRO is a dynamic ECG Holter recorder with up to 14 days of battery life; the TensioPod is an ambulatory blood pressure monitor; and the Kit Telemonitoraggio is a pre-configured six-parameter remote monitoring kit (oxygen saturation, heart rate, temperature, blood pressure, body weight, blood glucose). The Piattaforma Cloud aggregates device data, supports HL7 and API integration, and feeds a Centro Cardiologico reporting service coordinated by Prof. Sebastiano Marra that delivers ECG, Holter, blood pressure, and telemonitoring reports on flexible turnaround times from 20 minutes to 24 hours.
The company monetizes through a combination of hardware sales (devices), recurring platform subscriptions for the cloud, and professional reporting services (telereferring, Holter, ECG, and telemonitoring). Pricing is quote-based and contract terms are typically multi-year for enterprise customers. Distribution is omnichannel within Italy: direct field sales to hospitals, clinics, and government health authorities (such as ASL TO3); a pharmacy network reaching retail consumers; and a healthcare professional partner channel. The company reports an installed base of 2,500+ devices, 1,000+ active partners, and 400,000+ examinations processed through the platform. Cumulative disclosed funding is approximately $2.77M across a 2016 seed round and a 2017 round led by MedMe; the firm remains private and operates at an 11-50 employee scale.
Biotechware firmographics
Firmographics- Name
- Biotechware
- Legal name
- Aizoi
- Website
- https://biotechware.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biotechware, operating as Aizoi, is an Italian digital health company that combines proprietary cardiometabolic medical devices, a CE-marked cloud platform, and a 24/7 telereferring service to deliver screening, diagnosis, and remote monitoring for hospitals, pharmacies, and clinicians across Italy.
- Ownership category
- akta.pro rank
Biotechware industry classification
Industry- Product category
- Cardiometabolic Diagnostics & Telemedicine
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
- akta.pro secondary industries
- Cardiology Telemedicine Platforms (HLALAGAB), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
Keywords
Where Biotechware is headquartered
LocationHeadquarters
- HQ city
- Torino
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Biotechware business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Sale of proprietary medical devices including ECG Holter, blood pressure monitors, and cardiometabolic screening devices
- Software/Platform Services: Cloud platform subscription for data management, analysis, and telemedicine services
- Diagnostic Services: Telereferring and telemonitoring services with flexible reporting timelines from 20 minutes to 24 hours
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing for hospitals and clinics |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Biotechware product offering
Product offeringCore offering
Biotechware (commercial brand: Aizoi) sells an integrated cardiometabolic diagnostics and telemedicine offering that pairs proprietary medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) with a CE-marked cloud platform and a 24/7 cardiologist-led telereporting service. The platform enables contactless screening, ECG/Holter/blood-pressure reporting, and remote patient monitoring for hospitals, clinics, pharmacies, and healthcare professionals in Italy.
Product overview
Aizoi offers a holistic approach to easy and safe cardiometabolic diagnostics through digital health and telemedicine solutions for screening, diagnosis, and monitoring. The portfolio includes medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) supported by a cloud platform (Piattaforma Cloud) and professional medical reporting services (Centro Cardiologico, ECG a riposo, ECG Holter, Holter Pressorio, Telerefertazione, Telemonitoraggio). The platform enables integration with HL7 and API, providing healthcare professionals with tools for early cardiovascular disease detection, diagnosis, and post-diagnosis patient rehabilitation monitoring.
Differentiator
Problem solved
Functional benefit
Products and services
- TrAIcorder Contactless medical device for cardiometabolic screening that completes an assessment in 60 seconds without a blood draw, using rPPG technology and AI to analyze more than 25 vital and metabolic parameters. Designed for healthcare professionals, pharmacies, and clinical settings.
- CardioPad Lite Next-generation electrocardiograph that speeds up clinical workflows through patient data scanning via health card, an interactive guide for electrode placement, and direct report viewing/printing from a tablet. Intended for clinicians performing resting ECG examinations.
- Eclipse PRO Dynamic ECG (Holter) recorder designed for simplicity and patient comfort, with an integrated display, lightweight ergonomic design, 3 or 10 channel recording, 24/48-hour to 14-day battery life, and a waterproof rechargeable USB battery. Used for ambulatory cardiac monitoring.
- TensioPod Lightweight, silent, easy-to-wear blood pressure monitoring device using the oscillometric method with Inflation Measurement Technology, offering automatic wake/sleep period recording and up to 5 days of recording capacity for ambulatory blood pressure monitoring.
- Kit Telemonitoraggio Pre-configured remote patient monitoring kit that measures six parameters (oxygen saturation, heart rate, temperature, blood pressure, body weight, and blood glucose) and ships with a pre-configured smartphone and SIM for automatic data transfer to the Aizoi Cloud Platform.
- Piattaforma Cloud (Aizoi Cloud Platform) CE 0426-certified cloud platform for registering, analyzing, and sharing patient data, designed to be flexible and customizable with HL7 and API integration and accessible from PC and tablet without installation. Forms the data backbone connecting all Aizoi devices and services.
- Centro Cardiologico (Telereferring Service) 24/7 medical reporting center coordinated by Prof. Sebastiano Marra, staffed by cardiologists with proven telemedicine experience, providing reporting for ECG, Holter, and blood pressure monitoring analyses for partner hospitals, clinics, pharmacies, and physicians.
- ECG a riposo (Resting ECG Reporting Service) Resting ECG examination reporting service with flexible turnaround times ranging from 20 minutes to 24 hours depending on client needs.
- ECG Holter Reporting Service
Quantifiable outcome
- 60-second contactless cardiometabolic screening without blood draw
- +3 more outcomes
Companies that use Biotechware
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles4 records
Biotechware technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Biotechware partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Biotechware competitors and assessment
Company assessmentDirect peers
- iRhythm Technologies: iRhythm's Zio service provides continuous ambulatory cardiac monitoring with AI-based ECG analysis and a cloud reporting platform — directly mirroring Aizoi's combination of wearable cardiac devices, cloud platform, and specialist reporting for arrhythmia and cardiometabolic diagnostics.
- Cardiolex: Swedish company providing ECG analysis services, Holter, and cloud-based cardiology reporting — closely matching Aizoi's diagnostic services and cloud-platform offering, though serving a Nordic/European footprint rather than Italy.
Regional players
- Vitaphone: German-headquartered provider of telehealth, telemonitoring, and RPM services with a particular strength in cardiology across DACH and broader Europe. Comparable in offering RPM kits, cloud platform, and cardiac telemedical reporting, primarily serving European markets.
Broad incumbents
- Tunstall Healthcare: UK-based provider of telecare and telehealth solutions, including RPM for chronic cardiac and metabolic conditions across Europe. Comparable in tele-monitoring kits, cloud infrastructure, and managed services, but with a much broader care portfolio spanning elderly and chronic care.
- Medtronic (LINQ / CareLink Network): Medtronic's LINQ insertable cardiac monitor streams data through the CareLink network, and the company sells broader cardiovascular devices. Comparable as a remote cardiac monitoring platform, though Medtronic focuses on implantable diagnostics and operates at vastly larger global scale.
- Philips (BioTelemetry / Remote Cardiac Monitoring): Philips acquired BioTelemetry and offers a broad portfolio of ambulatory ECG, Holter, and remote cardiac monitoring services. Highly comparable as a cardiology-focused monitoring services and device provider, but operating globally at much larger scale with a wider product portfolio.
- GE Healthcare (MUSE and ECG/Holter portfolio): GE Healthcare sells resting ECG, Holter, and stress testing systems widely used in hospitals and clinics, plus the MUSE cardiology information system. Overlaps with Aizoi's hospital-facing diagnostic devices and cloud-based reporting infrastructure, but as part of a much broader imaging and monitoring franchise.
Emerging players
- eDevice: European connected-health company providing cellular gateways and cloud infrastructure to connect medical devices for RPM. Adjacent peer with overlapping technology stack (device connectivity + cloud platform) used by cardiac and chronic-disease monitoring programs similar to Aizoi's Kit Telemonitoraggio.
- Hilo (formerly Aktiia): Swiss company offering cuffless continuous blood pressure monitoring and a connected health platform with AI analysis — closely comparable to Aizoi's contactless TrAIcorder and TensioPod continuous BP monitoring approach for cardiometabolic screening and management.
Others
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biotechware social profiles
Digital presenceBiotechware financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biotechware leadership team
Management profileNumber of profiles
Profiles3 records
Biotechware funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biotechware M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biotechware
What does Biotechware do?
Biotechware (commercial brand: Aizoi) sells an integrated cardiometabolic diagnostics and telemedicine offering that pairs proprietary medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) with a CE-marked cloud platform and a 24/7 cardiologist-led telereporting service. The platform enables contactless screening, ECG/Holter/blood-pressure reporting, and remote patient monitoring for hospitals, clinics, pharmacies, and healthcare professionals in Italy.
Is Biotechware a public or private company?
Biotechware is a private company. It is classified as venture growth investor backed and is currently operating.
When was Biotechware founded?
Biotechware was founded in 2011. It employs 11 to 50 people.
Where is Biotechware based?
Biotechware is headquartered in Torino, Italy, in the Europe region.
How does Biotechware make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are software/Platform Services and diagnostic Services.
Who are Biotechware's main competitors?
Direct peers on record are iRhythm Technologies and Cardiolex. Vitaphone is listed as a regional player. Broad incumbents are Tunstall Healthcare, Medtronic (LINQ / CareLink Network), Philips (BioTelemetry / Remote Cardiac Monitoring) and GE Healthcare (MUSE and ECG/Holter portfolio). Emerging players are eDevice and Hilo (formerly Aktiia). Boston Scientific (Preventice Solutions) is listed as an others.
Does Biotechware have an API?
No public API is recorded for Biotechware.
What industry is Biotechware in?
Biotechware's product category is Cardiometabolic Diagnostics & Telemedicine. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.